Microglia-derived APOE2 improves remyelination even in the presence of endogenous APOE4.
Ontology highlight
ABSTRACT: Demyelination occurs with aging and is exacerbated in neurodegenerative diseases. During demyelination, microglia upregulate expression of APOE, the gene encoding for the brain's primary lipid transport protein apolipoprotein E (ApoE), which also mediates microglial engulfment and elimination of myelin debris. Compared to the E3 allele of APOE, the E2 allele decreases risk for Alzheimer's disease (AD), while the E4 allele increases AD risk and is associated with an increased severity and progression of multiple sclerosis. Previous work shows that mice expressing E2 exhibit improved microglial function and remyelination compared to mice expressing E4. However, whether microglial-derived APOE is responsible for driving these differences following demyelination, and if microglia-selective exp
SUBMITTER: Nolt GL
PROVIDER: S-EPMC12802005 | biostudies-literature | 2025 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA